E LENV 4 mg (Lenvima 4 mg)
Generic Name: lenvatinib
Pill with imprint E LENV 4 mg is Red, Capsule-shape and has been identified as Lenvima 4 mg. It is supplied by Eisai Co., Ltd.
Lenvima is used in the treatment of endometrial cancer; thyroid cancer; hepatocellular carcinoma; renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. Lenvima 4 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E LENV 4 mg
Lenvima
- Generic Name
- lenvatinib
- Imprint
- E LENV 4 mg
- Strength
- 4 mg
- Color
- Red
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eisai Co., Ltd.
- National Drug Code (NDC)
- 62856-0712
More about Lenvima (lenvatinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (2)
- Patient tips
- Drug images
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- FDA approval history
Patient resources
- Drug Information
- Lenvima (Advanced Reading)
- Lenvima (14 MG Daily Dose)
- Lenvima (18 MG Daily Dose)
- Lenvima (20 MG Daily Dose)
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.